A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids

CompletedOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Leiomyoma
Interventions
OTHER

No Intervention

No intervention is administered in this study.

Trial Locations (20)

T2E 7W7

Peter Lougheed Centre/University of Calgary, Calgary

T5T 1L6

Urestky Edmonton Clinic, Edmonton

V5Z 4E1

Sanders Vancouver Clinic, Vancouver

V6H 3N1

Children's and Women's Health Centre of British Columbia - The University of British Columbia, Vancouver

V4B 5C9

Southern Health Centre, White Rock

E3B 6H5

Landau Fredericton Clinic, Fredericton

L6G 0B5

Strand Clinic, St. John's

B3K 6R8

IWK Healtch Centre, Halifax

L8S 4K1

Hamilton Health Sciences, Hamilton

N6A 5W9

Minimally Invasive Gynecology Clinic, London

K1H 7W9

Ottawa Hospital Research Institute, Ottawa

M5C 2T2

St. Micheals Hospital, Toronto

M5G 1Z5

Mount Sinai Hospital, Toronto

N9C 1X2

South Windsor Women's Health, Windsor

H8N 1T9

Centre Gynécologie et Maternité, LaSalle

H3S 1Y9

Jewish General Hospital, Montreal

J4N 1C2

Clinique de Gynécologie & Obstétrique Pierre Boucher, Montreal

H4R 0B7

Complexe Medical Saint-Laurent, Saint-Laurent

S4S 6X3

University of Saskatchewan, Regina

G1V 4G2

CHU de Québec-Universite Laval, Québec

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY